- Press Release Distribution

Organizations collaborate to develop international von Willebrand Disease guidelines

( The American Society of Hematology (ASH), the International Society on Thrombosis and Haemostasis (ISTH), National Hemophilia Foundation (NHF), and World Federation of Hemophilia (WFH) have developed joint clinical practice guidelines on the diagnosis and management of von Willebrand Disease (VWD), the world's most common inherited bleeding disorder. The guidelines were published today in Blood Advances.

VWD affects approximately 1% of the world's population, and it is the most common bleeding disorder. Although VWD occurs among men and women equally, women are more likely to notice the symptoms because of heavy or abnormal bleeding during their menstrual periods and after childbirth. This inherited condition results in the decreased production, absence, or abnormal function of the clotting protein von Willebrand factor.

VWD can cause unusual bleeding from small wounds or minor procedures, frequent nosebleeds, bruising, bleeding in joints, and heavy menstrual periods and post-partum bleeding in women. Symptoms may vary from patient to patient or in a single patient over the course of his or her life. Primary care providers, pediatricians, obstetricians, and gynecologists who observe unusual bleeding often refer their patients to a hematologist for further testing and management. Many individuals with mild symptoms do not receive a diagnosis right away and live for many years with untreated bleeding or do not realize they have VWD until they experience a severe bleed that could have been prevented.

"While VWD is a common bleeding disorder, it is also complex, presenting challenges in the timely diagnosis and appropriate management of bleeding for patients," said 2021 ASH President Martin S. Tallman, MD, of Memorial Sloan Kettering Cancer Center. "Because diagnosis is not straightforward and symptoms range in severity, there is a need for trustworthy guidelines to help improve the quality of care for patients. There are no better partners for ASH in this effort than ISTH, NHF, and WFH, whose collective expertise in VWD from the scientific and patient perspectives around the world enhanced this effort."

Notably, the guidelines make key statements on thresholds of laboratory testing to classify VWD to be more inclusive of patients who experience bleeding, but whose blood work does not meet currently accepted thresholds for diagnosis. In addition, the guidelines for the first time recommend that VWD patients who suffer from frequent, severe bleeding that decreases quality of life should receive routine VWD prophylaxis - an injectable concentrate of clotting protein - several times a week. Together, the guidelines on diagnosis and management include a combined 19 recommendations.

The guidelines were developed by two expert panels made up of 32 individuals, including U.S.-based and international hematologists, individuals living with VWD, and scientists with expertise in evidence synthesis and appraisal and guideline development methodology. Clinical questions were developed by the panels and prioritized, and an international survey was completed to identify the most important clinical questions. A systematic review of available evidence was conducted by the University of Kansas Medical Center and the panel referred to this evidence to make recommendations. This process shed light on the lack of strong evidence on which to base recommendations, and therefore the report calls for more research.

"These guidelines are an excellent example of collaboration across multiple societies ensuring that the guidelines develop represent the most up to date and relevant advice about diagnosis and treatment of this common, but often misunderstood bleeding disorder," said ISTH Past President Claire McLintock, MD. "Working as part of the incredible team that developed the guidelines in diagnosis of VWD was hugely rewarding and inspiring." People with VWD made up approximately one quarter of each guideline panel's composition. As full voting members they contributed their expertise to every aspect of the rigorous guideline development process, from the prioritization of clinical questions, through the evaluation of the available evidence, to the consideration of factors such as stakeholder values and preferences, equity, and feasibility. Their involvement, actively supported by the panel chairs and collaborating organizations, was critical to ensuring the development of recommendations with the greatest pertinence and in which the community will have great confidence. Collaboration with WFH and NHF was essential to engaging the broader VWD patient community.

With their extensive established functional networks with healthcare professionals in centers for comprehensive care of bleeding disorders and patient organizations throughout the US and around the world, the four collaborating organizations, ASH, ISTH, NHF, and WFH will all play important roles in the creation and dissemination of resources based on the guidelines, and their implementation in individual care and broader advocacy efforts.

"These guidelines are an extremely important step in our quest to address the difficulties individuals go through to obtain an accurate, timely diagnosis, and appropriate treatment. The challenge ahead will be for us to educate both those living with VWD and healthcare professionals on the guideline recommendations," said Leonard Valentino, MD, President and CEO of NHF. "We were excited to work with ASH, ISTH, and WFH to create these and introduce them to the community." "In 2017 we gathered members of the global VWD community for the first WFH International Symposium on VWD. Delegates from countries around the world told us that the number one tool they needed in order to provide comprehensive care to people with VWD was clinical practice guidelines," explained WFH President Cesar Garrido. "The WFH is very proud to deliver these guidelines today, with our partners from ASH, ISTH, and NHF, to the global community. In addition to offering guidance for clinicians and individuals with VWD as they partner in personalized care decisions, they constitute the foundation for important advocacy initiatives to improve access to the recommended diagnostic techniques and treatment options in all countries." The publication of the guideline will be accompanied by tools and educational resources to help patients, hematologists and other health care providers understand and implement the recommendations.


Related links about the new VWD guidelines: VWD guidelines in Blood Advances ASH resources ISTH resources NHF resources WFH resources

About the American Society of Hematology The American Society of Hematology is the world's largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 60 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood?, the most cited peer-reviewed publication in the field, and Blood Advances, an online, peer-reviewed open access journal. For more information about ASH's portfolio of clinical practice guidelines, visit

About the International Society of Thrombosis and Haemostasis Founded in 1969, the ISTH is the leading worldwide not-for-profit organization dedicated to advancing the understanding, prevention, diagnosis and treatment of thrombotic and bleeding disorders. ISTH is an international professional membership organization with more than 7,700 clinicians, researchers and educators working together to improve the lives of patients in more than 110 countries around the world. Among its highly regarded activities and initiatives are education and standardization programs, research activities, meetings and congresses, peer-reviewed publications, expert committees and World Thrombosis Day on 13 October. Visit ISTH online at About the National Hemophilia Foundation NHF (the National Hemophilia Foundation) is a 501(c)(3) nonprofit organization dedicated to finding better treatments and cures for inheritable bleeding disorders and to preventing the complications of these disorders through education, advocacy and research. NHF's programs and initiatives are made possible through the generosity of individuals, corporations and foundations, as well as through a cooperative agreement with the Centers for Disease Control and Prevention (CDC). Additional information on hemophilia and NHF can be found at

About the World Federation of Hemophilia For over 50 years, the World Federation of Hemophilia (WFH), an international not-for-profit organization, has worked to improve the lives of people with hemophilia and other inherited bleeding disorders. Our vision of Treatment for All is that one day, all people with a bleeding disorder will enjoy a more certain future filled with promise, no matter where they live. For decades, we have been working around the world to improve diagnosis, treatment and ensure patients have sustainable access to care. We have a responsibility to deliver life-changing programs and services. Established in 1963, the WFH is a global network of patient organizations in 147 countries and has official recognition from the World Health Organization. Visit WFH online at


Scientists identify 'immune cop' that detects SARS-CoV-2

Scientists identify immune cop that detects SARS-CoV-2
LA JOLLA, CALIF. - Jan 12, 2020 - Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified the sensor in human lungs that detects SARS-CoV-2 and signals that it's time to mount an antiviral response. The study, published today in Cell Reports, provides insights into the molecular basis of severe disease and may enable new strategies for the treatment and prevention of COVID-19. "Our research has shown that MDA-5 is the immune cop that's tasked to keep an eye out for SARS-CoV-2 and call for back-up," says Sumit Chanda, Ph.D., director of the Immunity and Pathogenesis Program at Sanford Burnham Prebys and senior author of the study. ...

When AI is used to set prices, can inadvertent collusion be a result?

Key Takeaways: Machine learning can be an effective tool to set competitive prices. Artificial intelligence has its limits on how to set the most effective prices due to variables beyond the seller's control. Over the long term, supracompetitive pricing can result. CATONSVILLE, MD, January 12, 2021 - Machine learning and artificial intelligence (AI) are perfectly suited to help companies and marketers monitor and set prices based on real-time dynamic pricing. But new research has identified some possible unintended consequences of AI in this area. Machine learning algorithms don't always account for factors outside of the seller's control, such as competitor prices. Researchers ...

More than half of COVID-19 health care workers at risk for mental health problems

The daily toll of COVID-19, as measured by new cases and the growing number of deaths, overlooks a shadowy set of casualties: the rising risk of mental health problems among health care professionals working on the frontlines of the pandemic. A new study, led by University of Utah Health scientists, suggests more than half of doctors, nurses, and emergency responders involved in COVID-19 care could be at risk for one or more mental health problems, including acute traumatic stress, depression, anxiety, problematic alcohol use, and insomnia. The researchers found that the risk of these mental health conditions was comparable to rates observed during natural disasters, such as 9/11 and Hurricane Katrina. "What health care workers are experiencing is akin to domestic combat," says ...

Enhanced oral uptake of exosomes opens cell therapy alternative

Enhanced oral uptake of exosomes opens cell therapy alternative
LOS ANGELES (Jan. 11, 2021) -- Cell-derived exosomes are effective in treating disease when mixed with the dominant protein in breast milk and given orally, a new Smidt Heart Institute study of laboratory mice shows. The findings, published in the peer-reviewed Journal of Extracellular Vesicles, could help develop new oral medications for treating patients with muscular dystrophy and heart failure. The study builds on more than a decade of research led by Eduardo Marbán, MD, PhD, executive director of the Smidt Heart Institute and Cedars-Sinai professor of Cardiology. The research has focused on human cardiosphere-derived ...

Johns Hopkins scientist develops method to find toxic chemicals in drinking water

Most consumers of drinking water in the United States know that chemicals are used in the treatment processes to ensure the water is safe to drink. But they might not know that the use of some of these chemicals, such as chlorine, can also lead to the formation of unregulated toxic byproducts. Johns Hopkins Environmental Health and Engineering Prof. Carsten Prasse proposes a new approach to assessing drinking water quality that could result in cleaner, safer taps. "We are exposing people in the United States to these chemical compounds without knowing what they ...

NASA missions help investigate an 'Old Faithful' active galaxy

During a typical year, over a million people visit Yellowstone National Park, where the Old Faithful geyser regularly blasts a jet of boiling water high in the air. Now, an international team of astronomers has discovered a cosmic equivalent, a distant galaxy that erupts roughly every 114 days. Using data from facilities including NASA's Neil Gehrels Swift Observatory and Transiting Exoplanet Survey Satellite (TESS), the scientists have studied 20 repeated outbursts of an event called ASASSN-14ko. These various telescopes and instruments are sensitive to different wavelengths of light. By using them collaboratively, scientists obtained more detailed pictures of the outbursts. "These are the most predictable and frequent recurring multiwavelength ...

Wearable electronics for continuous cardiac, respiratory monitoring

Wearable electronics for continuous cardiac, respiratory monitoring
WASHINGTON, January 12, 2021 -- A highly sensitive wearable sensor for cardiorespiratory monitoring could potentially be worn continuously by cardiac patients or others who require constant monitoring. The small and inexpensive sensor, announced in Applied Physics Letters, by AIP Publishing, is based on an electrochemical system involving two ionic forms of iodine, I- and I3-. A solution containing these electrolyte substances is placed into a small circular cavity that is capped with a thin flexible diaphragm, allowing detection of subtle movements when placed on a patient's chest. Small motions that arise from the heartbeat and breathing cause the flexible diaphragm ...

Tissue stiffness likely drives immune responses in many chronic diseases

Stiffness in our tissues causes tension in our cells. Research from the Buck Institute, the University Health Network (University of Toronto), Stanford University, and the University of Alberta shows that stiffness impacts the innate immune system by upping its metabolism. The findings suggest the cellular tension likely sets off an inflammatory loop that contributes to the development of chronic diseases of aging. Publishing in Cell Reports, Buck Associate Professor Dan Winer, MD, and colleagues present an emerging way of looking at how the immune system functions, possibilities for new immunotherapeutics, and a call for scientists to reconsider the way they do research. While stiffness ...

Disposable helmet retains cough droplets, minimizes transmission to dentists

Disposable helmet retains cough droplets, minimizes transmission to dentists
WASHINGTON, January 12, 2021 -- The risk of infection of COVID-19 is high for medical specialists who come in contact with symptomatic or asymptomatic patients. Dentists and otolaryngologists are at particular risk, since they need direct access to the mouth, nose, and throat of patients. The current solutions, which include wearing N95 masks and face shields, clinic room evacuation, negative pressure rooms, and special air filtration systems, are expensive, not highly effective, and not very accessible. In Physics of Fluids, by AIP Publishing, researchers at Cornell University discuss their design of an open-faced helmet for patient use ...

Can sodium-ion batteries replace trusty lithium-ion ones?

Can sodium-ion batteries replace trusty lithium-ion ones?
WASHINGTON, January 12, 2021 -- Sodium-ion batteries are a potential replacement for lithium batteries, but the anodes -- positively charged electrodes -- that work well for lithium-ion batteries don't provide the same level of performance for sodium-ion batteries. Amorphous carbon, which lacks a crystalline structure, is known to be a useful anode, because it has defects and voids that can be used to store sodium ions. Nitrogen/phosphorus-doped carbon also offers appealing electrical properties. In Applied Physics Reviews, from AIP Publishing, researchers in China from Zhejiang University, Ningbo University, and Dongguan University of Technology ...


Study provides first real-world evidence of Covid-19 contact tracing app effectiveness

Myeloid immune cells in the blood tied to severe COVID-19

Scientists developed energy saving ceramic phosphors for high power LED systems

Roadblocks to success for PhD grads could mean missed opportunities for Canada

Corona vaccination: Approach receives approval

Researchers use nanomaterials to make 2D diamond clusters at room temperature

Reef fish futures foretold

When looking at species declines, nuances and long-term data are important

Solar hydrogen: Photoanodes made of alpha-SnWO4 promise high efficiencies

Intercontinental study sheds light on the microbial life of sourdough

Biodegradable displays for sustainable electronics

Autistic kids may have a harder time recognizing healthy vs. toxic arguments

A benchmark for single-electron circuits

UOC researchers have analysed 13 apps developed for the treatment and control of neglected tropical diseases, identifying the main weaknesses and evaluating possible improvements

At three days old, newborn mice remember their moms

Fighting racial inequity by funding Black scientists

Microwaves used to deactivate coronavirus, flu, other aerosolized viruses

Prevalence, risk factors associated with self-reported psychological distress among children, adolescents during COVID-19 pandemic in China

Neonatal antibiotic use associated with reduced growth in boys

Air purifiers may do more harm than good in confined spaces with airborne viruses

Nixing bone cancer fuel supply offers new treatment approach, mouse study suggests

Iron-carrying extracellular vesicles are key to respiratory viral-bacterial co-infection

A research team from Denmark discovers new control mechanism in the innate immune system

Soil health is as environmentally important as air and water quality, say microbiologists

The longevity gene mammalian Indy (mINDY) is involved in blood pressure regulation

Children cannot ignore what they hear when detecting emotions

Nuclear physicist's voyage towards a mythical island

Holocaust Remembrance Day: COVID-19 changed how we remember

Cancer deaths attributable to cigarette smoking in 152 US metropolitan and micropolitan areas

To combat false news, correct after reading

[] Organizations collaborate to develop international von Willebrand Disease guidelines